Followers | 827 |
Posts | 119518 |
Boards Moderated | 15 |
Alias Born | 09/05/2002 |
Sunday, March 12, 2017 5:52:23 PM
On 1/30/17, the US District Court invalidated TEVA’s ‘250, ‘413, ‘302, and ‘776 patents on 40mg Copaxone; this is MNTA’s PR on the Court judgment:
http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=1009734
TEVA has a fifth Orange Book patent on 40mg Copaxone: the ‘874 patent (http://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=020622&Appl_type=N ), which was filed by TEVA after MNTA submitted its 40mg-Copaxone ANDA and hence did not trigger a Paragraph-IV challenge by MNTA. Craig Wheeler has asserted on MNTA’s CCs that the ‘874 patent will have no consequence on MNTA because it’s an obvious follow-on to TEVA’s other four Orange Book patents on 40mg Copaxone that were recently invalidated.
TEVA also has a (non-Orange-Book) manufacturing process patent (the ‘775 patent) on 40mg Copaxone; however, Craig Wheeler has asserted on MNTA’s CCs that MNTA’s Copaxone manufacturing was designed around this patent and hence MNTA does not infringe it.
All told, there are no longer any legal impediments to NVS/MNTA’s launching 40mg Glatopa as soon as they obtain FDA approval.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM